SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-15-004838
Filing Date
2015-06-29
Accepted
2015-06-29 17:00:24
Documents
4
Period of Report
2015-06-29

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k062915pr_biondvax.htm 6-K 25366
2 PRESS RELEASE f6k062915prex99i_biondvax.htm EX-99.1 14162
3 GRAPHIC img_002.jpg GRAPHIC 736
4 GRAPHIC img_001.jpg GRAPHIC 15128
  Complete submission text file 0001213900-15-004838.txt   62652
Mailing Address 14 EINSTEIN ST. NES-ZIONA L3 74036
Business Address 14 EINSTEIN ST. NES-ZIONA L3 74036 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1213
Type: 6-K | Act: 34 | File No.: 001-37353 | Film No.: 15959001
SIC: 2836 Biological Products, (No Diagnostic Substances)